Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014', provides an overview of the Amorfix Life Sciences Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Amorfix Life Sciences Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Amorfix Life Sciences Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Amorfix Life Sciences Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Amorfix Life Sciences Ltd.'s pipeline products Reasons to buy - Evaluate Amorfix Life Sciences Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Amorfix Life Sciences Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Amorfix Life Sciences Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Amorfix Life Sciences Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Amorfix Life Sciences Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Amorfix Life Sciences Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Amorfix Life Sciences Ltd. Snapshot 4 Amorfix Life Sciences Ltd. Overview 4 Key Information 4 Key Facts 4 Amorfix Life Sciences Ltd. - Research and Development Overview 5 Key Therapeutic Areas 5 Amorfix Life Sciences Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Amorfix Life Sciences Ltd. - Pipeline Products Glance 12 Amorfix Life Sciences Ltd. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Amorfix Life Sciences Ltd. - Drug Profiles 14 ALS Therapeutic Vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 AMF-1c120 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 AMF-3d19 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Antibodies for Cancer 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Next Generation Monoclonal Antibody to Inhibit CD38 for cancer 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Amorfix Life Sciences Ltd. - Pipeline Analysis 21 Amorfix Life Sciences Ltd. - Pipeline Products by Target 21 Amorfix Life Sciences Ltd. - Pipeline Products by Molecule Type 22 Amorfix Life Sciences Ltd. - Pipeline Products by Mechanism of Action 23 Amorfix Life Sciences Ltd. - Recent Pipeline Updates 24 Amorfix Life Sciences Ltd. - Company Statement 26 Amorfix Life Sciences Ltd. - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Amorfix Life Sciences Ltd., Key Information 4 Amorfix Life Sciences Ltd., Key Facts 4 Amorfix Life Sciences Ltd. - Pipeline by Indication, 2014 7 Amorfix Life Sciences Ltd. - Pipeline by Stage of Development, 2014 8 Amorfix Life Sciences Ltd. - Monotherapy Products in Pipeline, 2014 9 Amorfix Life Sciences Ltd. - Out-Licensed Products in Pipeline, 2014 10 Amorfix Life Sciences Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 Amorfix Life Sciences Ltd. - Preclinical, 2014 12 Amorfix Life Sciences Ltd. - Discovery, 2014 13 Amorfix Life Sciences Ltd. - Pipeline by Target, 2014 21 Amorfix Life Sciences Ltd. - Pipeline by Molecule Type, 2014 22 Amorfix Life Sciences Ltd. - Pipeline Products by Mechanism of Action, 2014 23 Amorfix Life Sciences Ltd. - Recent Pipeline Updates, 2014 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.